Promising Alzheimer’s drug may also improve memory in Down syndrome and normal aging
New research is breaking ground in repurposing an FDA-approved drug as a potential treatment in Down syndrome and normal aging. The results suggest that GM-CSF
New research is breaking ground in repurposing an FDA-approved drug as a potential treatment in Down syndrome and normal aging. The results suggest that GM-CSF
Researchers have helped identify that a common protein found in neurodegenerative diseases forms amyloid filaments in an age-dependent manner without a connection to disease.
Cases of cognitive decline in older people, where a doctor has assessed someone following concerns about memory and noted their brain function has been affected,
New research has discovered how the enteric nervous system — or ‘second brain’ — can communicate with both the brain and spinal cord, which up
Researchers found that niacin limits Alzheimer’s disease progression when used in models in the lab, a discovery that could potentially pave the way toward therapeutic